DGAP-Adhoc

STADA Arzneimittel AG: Sales and earnings targets for 2014 at Group level met - crisis in the market region CIS/Eastern Europe requires impairments on goodwill as well as on further intangible assets in the expected amount of Euro 76.0 million before taxe - Seite 3

CIS/Eastern Europe 59.8
million

Burden from impairments on further intangible assets following + Euro
impairment tests including the market region CIS/Eastern Europe 41.5
million

Burden from currency effects recorded in the income statement + Euro
resulting from the fluctuation of the Russian ruble as well as 20.7
further significant currencies of the market region CIS/Eastern million
Europe

Burden from additional scheduled depreciation and other + Euro
measurement effects due to purchase price allocations as well as 10.6
significant product acquisitions taking financial year 2013 as million
basis

Net relief from several extraordinary expenses and income, among - Euro
other things, for payments made and received in connection with 7.4
damage claims million

Relief on earnings from effects of the measurement of derivative - Euro
financial instruments under financial income and expenses 3.6
million

Total one-time effects Euro
121.6
million

Net income, adjusted Euro
186.2
million




Additional information for analysts:
STADA Arzneimittel AG / Investor Relations / Stadastraße 2-18 / 61118 Bad
Vilbel - Germany / Phone: [phone] / Fax: [phone]
/ e-mail: [e-mail]

Additional information for journalists:
STADA Arzneimittel AG / Media Relations / Stadastraße 2-18 / 61118 Bad
Vilbel - Germany / Phone: [phone] / Fax: [phone]
/ e-mail: [e-mail]

Or visit us in the Internet at http://www.stada.com.


19.02.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------

Language: English
Company: STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel
Germany
Phone: [phone]
Fax: [phone]
E-mail: [e-mail]
Internet: www.stada.de
ISIN: DE0007251803, DE0007251845,
WKN: 725180, 725184,
Indices: MDAX
Listed: Regulated Market in Dusseldorf, Frankfurt (Prime Standard);
Regulated Unofficial Market in Berlin, Hamburg, Hanover,
Munich, Stuttgart

End of Announcement DGAP News-Service

---------------------------------------------------------------------------